Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2/3 1

Status

Completed 5Recruiting 1

Sponsor Class

OTHER 14INDUSTRY 5NIH 2OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Conditions

Polycystic Ovary Syndrome 5Infertility 3Anovulation 2

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Inositol × Clear all
NCT03667443 2025-07-11

Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients

Lo.Li.Pharma s.r.l

Phase NA Completed
50 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT06715527 2025-04-08

Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison

Lo.Li.Pharma s.r.l

Phase NA Completed
30 enrolled

Polycystic Ovary Syndrome

NCT05678114 2023-05-16

Inositol Treatment in Different Type of PCOS Phenotype

Lo.Li.Pharma s.r.l

Phase NA Completed
120 enrolled

Polycystic Ovary Syndrome

NCT03201601 2019-01-10

Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome

Biosearch S.A.

Phase 2/3 Completed
60 enrolled

Infertility, Polycystic Ovary Syndrome

NCT03422289 2018-02-06

Improved Effects of MI Plus Alpha-LA in PCOS

Lo.Li.Pharma s.r.l

Phase NA Completed
37 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡